Your Vitamin C Response Is Determined by Your Baseline: The Biomarker You Need to Check First

The surprising truth is vitamin C only helps some people. Most people take it daily and expect a boost. But if your labs are normal, nothing changes.

This means you should check your baseline first. Look at hs-CRP, uric acid, and glucose. If they are high, vitamin C may help you. If they are normal, save your money.

If your hs-CRP is over 3 mg/L, try 500–1,000 mg daily. If your uric acid is over 6.0 mg/dL, try 500 mg daily. Retest your labs in 8–12 weeks. Split doses like 500 mg twice daily if needed.

Your results from vitamin C depend on your baseline labs. Dose and brand matter less than your starting point. In a 396-person randomized trial, vitamin C lowered CRP by 25.3% in people who started high. It had little to no effect when CRP started normal [1].

This “baseline effect” shows up in other outcomes too. Meta-analyses of randomized trials report lower uric acid after vitamin C, with typical drops around 0.35–0.5 mg/dL. The biggest changes tend to occur when starting uric acid is higher (around or above 6.0 mg/dL) [2]. Lipid improvements also cluster in higher-risk groups, such as people with high cholesterol or diabetes, not people with normal lipids [3].

Why this happens is simple. Vitamin C helps most when your body is under strain. That can mean higher inflammation, oxidative stress, or low intake. When your systems are already in balance, extra vitamin C has little work to do.

Vitamin C's cardiovascular effects follow the same baseline-dependent pattern seen with inflammatory markers. A meta-analysis of randomized controlled trials found that vitamin C supplementation at 500-2000 mg daily improved endothelial function, but primarily in populations with existing cardiovascular risk factors or elevated oxidative stress [4]. The effect size was modest but statistically significant, with a standardized mean difference of 0.25.

The most dramatic cardiovascular effects occur during acute inflammatory states. A crossover trial using high-dose intravenous vitamin C demonstrated that it could completely restore endothelium-dependent vasodilation that had been impaired by lipopolysaccharide-induced inflammation [5]. While this represents an extreme experimental condition, it illustrates vitamin C's potential when the cardiovascular system is under oxidative stress.

For practical application, people with elevated CRP levels above 3.0 mg/L, existing cardiovascular disease, or metabolic syndrome are most likely to see cardiovascular benefits from vitamin C supplementation. Those with optimal cardiovascular health markers may see minimal additional benefit, though the safety profile makes supplementation low-risk even in healthy populations.

Vitamin C's role in bone health operates through a different mechanism than its antioxidant effects—collagen synthesis. This creates a threshold effect where adequate vitamin C is essential for maintaining bone density, but excess amounts don't necessarily provide additional benefits. Multiple meta-analyses have found positive associations between dietary vitamin C intake and bone mineral density at both the lumbar spine and femoral neck [6][7].

The most compelling evidence comes from longitudinal studies showing that people in the lowest tertile of vitamin C intake (7-57 mg daily) lost bone density at twice the rate of those with higher intakes [8]. Women in the lowest intake group lost bone mineral density at 0.65% per year compared to 0.30-0.31% in the middle and upper tertiles. This suggests a threshold effect where meeting basic collagen synthesis needs is critical, but megadoses don't accelerate bone building.

Cross-sectional analysis from a large randomized trial found that each 100 mg increase in vitamin C intake was associated with higher bone mineral density at the femoral neck and total hip [9]. However, this relationship appeared to plateau at moderate intake levels, supporting the threshold model rather than a linear dose-response relationship.

Use vitamin C like a targeted tool, not a default habit. Start with labs. If your markers are already good, you may not see a measurable change.

If your hs-CRP is elevated (often defined as above 3.0 mg/L for higher cardiovascular risk), studies commonly use 500–1,000 mg per day to improve inflammation-related markers. Take it with food if it upsets your stomach.

For uric acid, meta-analyses of randomized trials support 500 mg per day for modest lowering (about 0.35–0.5 mg/dL on average) [2]. Bigger doses do not reliably give bigger drops.

If you use higher intakes (such as 1,000–2,000 mg per day), split the dose (for example, 500 mg twice daily). This can fit vitamin C’s short blood half-life and limited absorption. Retest labs in 8–12 weeks and decide based on your results.

Vitamin C is not a guaranteed upgrade for everyone. It works best when your baseline markers show a problem to fix. If your hs-CRP or uric acid is high, 500–1,000 mg per day may lead to measurable improvements. If your labs are already in range, food sources of vitamin C are usually enough. The smartest move is simple: test, supplement with a clear goal, then retest.